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embrane-type 1 matrix metalloproteinase (MT1-
MMP) is an integral membrane proteinase that
degrades the pericellular extracellular matrix
(ECM) and is expressed in many migratory cells, including
invasive cancer cells. MT1-MMP has been shown to localize
at the migration edge and to promote cell migration;
however, it is not clear how the enzyme is regulated during
the migration process. Here, we report that MT1-MMP is
internalized from the surface and that this event depends
on the sequence of its cytoplasmic tail. Di-leucine (Leu
 
571–572
 
and Leu
 
578–579
 
) and tyrosine
 
573
 
 residues are important for
the internalization, and the 
 
 
 
2 subunit of adaptor protein
2, a component of clathrin-coated pits for membrane protein
M
 
internalization, was found to bind to the LLY
 
573
 
 sequence.
MT1-MMP was internalized predominantly at the adherent
edge and was found to colocalize with clathrin-coated
vesicles. The mutations that disturb internalization caused
accumulation of the enzyme at the adherent edge, though the
net proteolytic activity was not affected much. Interestingly,
whereas expression of MT1-MMP enhances cell migration
and invasion, the internalization-defective mutants failed to
promote either activity. These data indicate that dynamic
turnover of MT1-MMP at the migration edge by internaliza-
tion is important for proper enzyme function during cell
migration and invasion.
 
Introduction
 
Cells in tissue have to degrade and reconstitute the extracel-
lular matrix (ECM)* at the periphery to carry out various
cell functions such as migration, proliferation, and cell shape
change. Matrix metalloproteinases (MMPs) anchored to
plasma membrane, called membrane-type MMPs (MT-
MMPs), play pivotal roles for such limited ECM remodeling
(Werb, 1997; Nagase and Woessner, 1999; Seiki, 1999). Of
the six MT-MMPs that have been identified to date, four
(MT1-, MT2-, MT3-, and MT5-MMP) are anchored to
the plasma membrane via a transmembrane domain that is
followed by a short cytoplasmic tail (Pei, 1999; Seiki, 1999).
The remaining two MT-MMPs, MT4- and MT6-, are teth-
ered to the cell surface via a GPI anchor (Itoh et al., 1999;
Kojima et al., 2000).
Of all the MT-MMPs, MT1-MMP has been studied the
most. It degrades various ECM components including col-
lagens type I, II, and III, laminins 1 and 5, fibronectin, fi-
brin, and proteoglycans (Pei and Weiss, 1996; Ohuchi et al.,
1997; Koshikawa et al., 2000). It also activates other MMPs
on the cell surface including proMMP-2 (Sato et al., 1994)
and proMMP-13 (Knauper et al., 1996). MT1-MMP is ex-
pressed mainly in the mesenchymal tissues of embryos such
as bone, muscle, and fibroblastic tissues (Kinoh et al., 1996;
Apte et al., 1997). In the MT1-MMP–null mouse, forma-
tion of skeletal tissues is disturbed, and extensive fibrosis oc-
curs after birth (Holmbeck et al., 1999). Activation of
proMMP-2 was severely suppressed in this mouse (Zhou et
al., 2000) and isolated fibroblasts failed to digest type I col-
lagen (Holmbeck et al., 1999).
Overexpression of MT1-MMP is associated with malig-
nant tumors (Seiki, 1999). Because MT1-MMP expression
has been shown to augment the invasive and metastatic po-
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tential of cancer cells in experimental systems (Sato et al.,
1994; Tsunezuka et al., 1996), the enzyme is believed to
play a key role in the invasion of malignant tumors. Invasion
requires the dynamic and coordinated action of many cell
surface molecules including proteinases and adhesion mole-
cules (Horwitz and Parsons, 1999; Murphy and Gavrilovic,
1999). During this process, MT1-MMP is important not
only for ECM degradation but also for stimulating cell loco-
motion (Koshikawa et al., 2000; Kajita et al., 2001). During
cell migration, MT1-MMP localizes at the migration front
(Sato et al., 1997), particularly near the layer to which the
cells adhere (Kajita et al., 2001). However, it is still unclear
how MT1-MMP activity is regulated at the migration front
during cell migration.
In general, MT1-MMP activity on the cell surface is regu-
lated by several different mechanisms. ProMT1-MMP has a
recognition site for proprotein convertases at the end of the
propeptide (Sato et al., 1994). Therefore, MT1-MMP ap-
pears on the cell surface in its active form after proprotein
convertases cleave off the propeptide intracellularly (Yana
and Weiss, 2000). The enzyme activity on the cell surface
can be inhibited by the tissue inhibitors of metalloprotein-
ases (TIMPs)-2, -3, and -4 but not by TIMP-1. Of the
TIMPs, TIMP-2 is the major inhibitor of MT1-MMP
(Strongin et al., 1995). TIMP-2 also participates in the acti-
vation of proMMP-2 by MT1-MMP mediating the binding
of proMMP-2 to MT1-MMP through the formation of a
tri-molecular complex (e.g., proMMP-2–TIMP-2–MT1-
MMP) (Strongin et al., 1995; Butler et al., 1998; Kinoshita
et al., 1998). ProMMP-2 in the complex can then be acti-
vated by the adjacent TIMP-2–free MT1-MMP. Ho-
mophilic oligomer formation through the PEX domain
facilitates such bi-molecular events and stimulates the activa-
tion of proMMP-2 (Itoh et al., 2001). MT1-MMP is then
downregulated through the processing by MMP-2 and
MT1-MMP itself. The cleavage occurs within its catalytic
domain and generates a 43-kD inactive fragment on the cell
surface (Lehti et al., 1998; Stanton et al., 1998). Such an in-
active fragment may compete with the formation of homo-
oligomers of intact MT1-MMP molecules and eventually
inhibit proMMP-2 activation (Itoh et al., 2001). Another
proposed mechanism by which cell surface MT1-MMP ac-
tivity can be regulated is through its removal from the cell
surface by internalization and subsequent degradation. This
is suggested by a recent experiment showing that MT1-
MMP–bound TIMP-2 is internalized and degraded (Ma-
quoi et al., 2000).
In this paper, we report that MT1-MMP is indeed inter-
nalized at the cell surface and this process depends on ty-
rosine and di-leucine motifs in its cytoplasmic tail. In partic-
ular, the LLY
 
573
 
 motif was found to be the binding site of a
component of clathrin-coated pits, adaptor protein 2 (AP-
2). Although internalization is expected to regulate the net
amount of MT1-MMP present on the cell surface, we found
that the level of MT1-MMP activity in cells expressing in-
ternalization-defective mutants did not change significantly
in relation to those expressing the wild-type enzyme. De-
spite this, however, the MT1-MMP mutants, unlike wild-
type MT1-MMP, failed to promote cell migration and
invasion into reconstituted basement membrane. Because
 
MT1-MMP localizes at the cell adherent edge and is actively
internalized there, our results suggest that turnover of MT1-
MMP at the adherent edge by internalization is an impor-
tant step in regulating the enzyme during cell migration and
invasion.
Biochemical methods have been used to study membrane
proteinases. Although a biochemical approach is powerful, es-
pecially for soluble enzymes, it is not sufficient to characterize
the cell surface events that are coupled with various cell func-
tions, an equally important aspect of membrane protease reg-
ulation. From this point of view very little information about
cell surface proteinases is available. Our study provides an in-
teresting initial step to understanding the dynamic regulation
of MT1-MMP coupled with cell locomotion.
 
Results
 
Internalization of MT1-MMP in CHO-K1 cells
 
To study the internalization of MT1-MMP, we expressed
human MT1-MMP having a FLAG tag at the NH
 
2
 
 termi-
nus (MT1-F) in CHO-K1 cells, and monitored the fate of
MT1-F on the cell surface. Human transferrin receptor
(hTfnR), a well-characterized marker of endocytosis (Zuk and
Elferink, 1999), served as a positive control. The expression
of MT1-F or hTfnR by the transfected cells was confirmed
by Western blotting (Fig. 1 A, inset). To monitor the fate of
the cell surface molecules, either 
 
125
 
I-labeled anti-FLAG M2
antibody (
 
125
 
I-M2) or 
 
125
 
I-labeled human transferrin (
 
125
 
I-
hTfn) was used as a tracer. These ligands bound specifically
to the cells expressing MT1-F and hTfnR, respectively (un-
published data; Fig. 1 B). The cell surface ligands could be
removed almost completely by washing the cells with acid
solution (Fig. 1 A). Thus, the internalized tracer molecules
could be measured as the radioactivity that was resistant to
the acid wash.
After binding each ligand, the cells were incubated at
37
 
 
 
C to allow for internalization. The radioactivity in the
acid-resistant fraction (referred to as “Internalize”), the cul-
ture medium (Medium), and the fraction released by acid
wash (Cell surface) was measured after various incubation
times (Fig. 1 A). After a 30-min incubation, almost 60% of
the bound 
 
125
 
I-hTfn became acid resistant, presumably re-
flecting its internalization, after which it decreased (Fig. 1
A). This is consistent with observations made previously by
Zuk and Elferink (1999). The time-dependent transition of
surface-bound 
 
125
 
I-M2 to the acid-resistant fraction was sim-
ilar to that of 
 
125
 
I-hTfn, which showed 40% internalization
after a 30-min incubation and a decrease thereafter. After a
60-min incubation, the majority of the radioactivity was
found in the Medium fraction. Thus, the tracers that were
once internalized were released again into the medium.
Almost 40% of the M2 antibody was released during the first
10-min incubation even in the cells fixed with 3% paraformal-
dehyde (unpublished data). Although we do not know how this
weak binding occurs, a fraction of MT1-F may be processed
partially from the NH
 
2
 
-terminal FLAG sequence. Thus, there
is a possibility that the efficiency of MT1-F internalization is
underestimated. We also analyzed the internalization using a
monovalent Fab fragment derived from the M2 antibody and
obtained similar results, indicating that internalization is not an 
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cellular, 0 min). The cell surface–bound M2 antibody de-
creased thereafter, suggesting that the M2 antibody was ei-
ther being internalized together with the MT1-F molecules
or was released from the surface. Intracellular signals of the
M2 antibody increased according to the incubation time
(Intracellular, 10 and 30 min) indicating that the M2 anti-
body bound to the cell surface MT1-F was incorporated
into the cells. However both surface and intracellular signals
became weak after a 60-min incubation (60 min). Thus, the
internalization of the cell surface MT1-MMP molecules was
visually confirmed again.
 
Internalization of MT1-MMP depends on sequences in 
its cytoplasmic tail
 
The internalization of surface proteins depends on specific se-
quences in the cytoplasmic tail that direct incorporation of the
molecules into clathrin-coated vesicles (Heilker et al., 1999).
MT1-MMP itself may bear such signals on its cytoplasmic
tail. Alternatively, it may associate with other proteins having
such internalization motifs. We first located the MT1-MMP
domain that is essential for internalization by constructing
various deletion mutants as shown in Fig. 2 A. Comparable
levels of expression for each construct were confirmed by
Western blotting (Fig. 2 B). The amount of each mutant on
the cell surface was measured by the amount of cell surface–
bound 
 
125
 
I-M2 (Fig. 2 C). The internalization of each mutant
was then analyzed after a 30-min incubation. Deletion of ei-
ther the catalytic (
 
 
 
CAT) or the PEX domain (
 
 
 
PEX) did
not affect internalization (Fig. 2 D). However, deletion of the
cytoplasmic tail (
 
 
 
CP) or its substitution with the cytoplas-
mic tail derived from the interleukin 2 receptor 
 
 
 
 chain
(IL2R) dramatically reduced internalization (Fig. 2 D). We
also tested another chimeric MT1-F molecule, MT1-F(GPI),
wherein the MT1-F transmembrane domain and the cyto-
plasmic tail had been substituted with the GPI-anchoring sig-
nal derived from MT4-MMP. The internalization of this mu-
tant molecule was also reduced (Fig. 2 D). These observations
indicate that the cytoplasmic tail of MT1-MMP contains the
critical sequences required for internalization. These se-
quences are either internalization signals or the site through
which MT1-MMP interacts with other molecules that con-
tain internalization signal motifs.
 
Delineation of the internalization signals in the 
cytoplasmic tail
 
To delineate the sequences that are essential for MT1-MMP
internalization, a series of deletions were introduced into the
MT1-MMP cytoplasmic tail (Fig. 3 A). After confirming the
expression levels and the cell surface amounts of each mutant
(Fig. 3 B), which did not differ from the wild-type protein, the
internalization of each mutant was measured (Fig. 3 C). Dele-
tion of four (
 
 
 
579) and eight (
 
 
 
575) amino acids from the
COOH terminus resulted in a slight decrease (20%) in inter-
nalization, whereas a significant reduction (60%) was observed
with the 
 
 
 
571 mutant that lacks 12 amino acids. Further dele-
tion did not reduce the internalization significantly. Thus, it
appears that the last four amino acids, LLYC
 
574
 
, of the 
 
 
 
575
mutant constitute an important internalization signal. Consis-
tent with this observation, internal deletion of the LLYC
 
574
 
amino acids (
 
 
 
571–574) reduced internalization by 50%.
artificial event caused by the cross-linking of MT1-MMP mole-
cules by the divalent antibody (unpublished data).
To ensure that the acid-resistant radioactivity of 
 
125
 
I-M2
was a direct indication of the incorporation of molecules
into the cells, the M2 antibody was visualized by immuno-
staining. The M2 antibody bound to cell surface MT1-F
(Fig. 1 B, Surface fraction) was exclusively stained without
permeation of the cells. The internalized antibody together
with MT1-F was stained exclusively after removing the cell
surface antibody by the acid wash and permeating the cell
membrane. The M2 antibody bound to the cells expressing
MT1-F, but not to the mock-transfected cells (Surface, 0
min). Internalized signals were not detected at time 0 (Intra-
Figure 1. Internalization of wild-type MT1-MMP in CHO-K1 
cells. (A) CHO-K1 cells were transfected with expression plasmids 
for MT1-F or hTfnR. 48 h later, the internalization of cell surface–
expressed MT1-F or hTfnR was examined using 
125I-labeled anti-
FLAG M2 antibody or 
125I-labeled hTfn as tracer ligands. The 
radioactivity relative to the amount of tracers bound to the surface 
at time 0 is plotted.  , radioactivity spontaneously released into the 
culture medium (Medium);  , radioactivity released by acid wash 
(Cell surface);  , acid wash–resistant radioactivity (Internalize). 
Mean values of three independent experiments are shown (mean   
SD). Transfected cells were also analyzed by Western blotting 
using anti-FLAG M2 or anti-hTfnR antibodies (inset). (B) CHO-K1 
cells expressing MT1-F or mock-transfected cells were incubated 
with anti-FLAG M2 antibody, after which the cells were incubated 
at 37 C for the indicated periods of time. The cell surface and inter-
nalized MT1-F molecules were analyzed by immunolocalization 
using Alexa
TM488-conjugated anti–mouse IgG. Internalized MT1-F 
molecules were observed by washing the cells with acid solution 
before fixation and permeabilization. Signals were observed by con-
focal laser microscopy. Bar, 10  m. 
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the molecules via clathrin-coated pits. Tyrosine and di-leucine
motifs are both potential binding sites for AP-2 (Hunziker and
Fumey, 1994). Binding of AP-2 to the cytoplasmic tail of cell
surface proteins is mediated by its subunit 
 
 
 
2, which recog-
nizes tyrosine-containing motifs (Ohno et al., 1995). Such in-
teractions can be detected by using the yeast two-hybrid system
(Ohno et al., 1996). As we found that LLY
 
573
 
 serves as a cis-
acting element in MT1-MMP internalization, we tested
whether LLY
 
573
 
 is the binding site for the 
 
 
 
2 subunit. We used
the 20–amino acid cytoplasmic tail of MT1-MMP as the
“bait” by fusing it with the GAL4 DNA binding domain
(GAL4DB), and the GAL4 activator domain fused with the
 
 
 
2 fragment served as the “prey.” The trans-Golgi network–
specific integral membrane protein (TGN38) was used as a
positive control for these experiments as its cytoplasmic tail is
known to bind to 
 
 
 
2 (Ohno et al., 1996). GAL4DB alone
(Mock) did not interact with 
 
 
 
2, whereas TGN38 did (Fig. 5
A, TGN38). When the cytoplasmic tail of MT1-MMP was
tested, it gave a strong positive signal similar to TGN38 (Fig. 5
A, MT1-WT), suggesting that it interacts with the 
 
 
 
2 subunit.
To confirm the importance of the LLY motif in this interac-
tion, it was mutated to alanines (MT1-L1Y/A) and examined.
MT1-L1Y/A did not interact with 
 
 
 
2. Thus, the LLY
 
573
 
 motif
appears to be the site that interacts with clathrin-coated pits.
Next, we assessed whether the internalized MT1-F colo-
calizes with clathrin. Cells expressing MT1-F or its cyto-
plasmic mutants were reacted with Texas red–labeled
anti-FLAG M2 antibody and incubated for 5 min to allow
internalization. Then, cell surface antibodies were removed
 
The tyrosine (Y
 
573
 
) and di-leucine (LL
 
572
 
, referred to as L1)
residues in the deleted sequence are found in the internaliza-
tion motifs that have been reported previously (Heilker et al.,
1999). Another di-leucine sequence (LL
 
579
 
, referred to as L2)
was also found in the tail sequence. To determine which of
these motifs participates in the MT1-MMP internalization,
targeted mutations were introduced into one or more of the
three motifs (Fig. 4 A). Mutation of either of the two di-leu-
cine sequences to alanines (L1/A or L2/A) reduced internaliza-
tion by 53 and 33%, respectively (Fig. 4 C). Mutation of both
di-leucines showed a slightly additive effect (55% decrease).
Mutation of tyrosine
 
573
 
 to alanine (Y/A) also reduced internal-
ization by 40% and combining this mutation with L1/A
(L1Y/A) inhibited it further (53%). Combined mutations in
all three sites (L1YL2/A) reduced internalization to levels
comparable with the cytoplasmic deletion mutant (
 
 
 
CP;
63%). In contrast, mutating either of the other two amino ac-
ids, i.e., serine
 
577
 
 (S/A) and valine
 
582
 
 (V/A), to alanine had no
effect on internalization. The expression of the mutant MT1-
MMPs and their cell surface amounts were confirmed and did
not differ from the wild-type protein (Fig. 4 B).
 
Interaction of adaptor protein subunit 
 
 
 
2 
with the LLY
 
573
 
 motif in the cytoplasmic tail 
suggests internalization of MT1-MMP via 
clathrin-coated vesicles
 
The binding of AP-2 to the cytoplasmic tail of membrane pro-
teins is the first step in the process that causes internalization of
Figure 2. Identification of the domain involved in MT1-MMP 
internalization in CHO-K1 cells. (A) Schematic representation of 
MT1-MMP mutants used in this experiment. SP, signal peptide; Pro, 
propeptide; CAT, catalytic domain; H, hinge; PEX, hemopexin-like 
domain; TM, transmembrane domain; CP, cytoplasmic domain; 
FLAG, FLAG epitope; GPI, glycosylphosphatidylinositol anchor. (B) Western blot analysis of MT1-MMP mutants expressed in CHO-K1 cells. 
Molecules expressed in the transfected cells were detected by anti-FLAG M2 antibody. The asterisks (*) indicate the nonspecific band. (C) 
Amount of MT1-F and mutants expressed on the cell surface calculated from the bound 
125I-labeled anti-FLAG M2 antibody. Values are 
the mean   SD of three experiments. (D) Internalization of MT1-MMP mutants after a 30-min incubation. Experiments were performed as 
described in Fig. 1 and the Materials and methods. Values are the mean   SD of three experiments. The asterisks (*) indicate statistically 
significant differences (P   0.001) between MT1-F and the mutant. 
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Figure 3. Effect of deleting the cytoplasmic domain on MT1-MMP 
internalization. (A) Schematic representation of the MT1-MMP 
cytoplasmic domain deletion mutants. (B) Transiently expressed 
products in CHO-K1 cells were analyzed by Western blotting using 
anti-FLAG M2 antibody. Amount of cell surface MT1-F and mutant 
proteins was calculated from the bound 
125I-labeled anti-FLAG M2 
antibody. (C) Internalization of MT1-F and its mutant proteins after a 
30-min incubation was analyzed as in Fig. 1. Values in B and C are 
the mean   SD of three experiments. The asterisks (*) indicate 
statistically significant differences (P   0.001) between MT1-F and 
the mutant. Figure 4. Effect of site-directed mutations on MT1-MMP internal-
ization. (A) Schematic representation of the MT1-MMP cytoplasmic 
sequence and mutations. (B) Transiently expressed products in 
CHO-K1 cells were analyzed by Western blotting using anti-
FLAG M2 antibody. Amount of cell surface MT1-F and mutant 
proteins was calculated from the bound 
125I-labeled anti-FLAG 
M2 antibody. Values indicate the mean   SD of three experiments. 
(C) Internalization of MT1-F and its mutant proteins after a 30-
min incubation was analyzed as in Fig. 1. Values are the mean   
SD of three experiments. The asterisks (*) indicate statistically 
significant differences (P   0.001) between MT1-F and the 
mutant.
 
completely by washing with acid solution, and the internal-
ized molecules were selectively visualized. The internalized
MT1-F molecules were detected in a dot-like pattern at the
proximity of the adherent edge of the cell (Fig. 5 B). In the
same cell, clathrin was immunostained as numerous dot-like
aggregations scattering over the cell (green fluorescence).
When these images were merged, the signals of internalized
MT1-F overlapped closely with those of clathrin. When 
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MT1-F(L1Y/A)– or MT1-F(
 
 
 
CP)–expressing cells and
mock-transfected cells were examined, such internalized M2
antibody signals were not observed at all.
 
A defect in MT1-MMP internalization does not affect 
its ability to activate proMMP-2
 
To examine whether MT1-MMP internalization affects
MT1-MMP activity on the cell surface, we analyzed the
ability of the MT1-MMP mutants to activate proMMP-2,
which is one of the important functions of MT1-MMP.
MT1-MMP constructs with various mutations in the cyto-
plasmic domain were expressed in CHO-K1 cells, and
their ability to activate the proMMP-2 in the culture me-
dium was examined (Fig. 6 A). None of the mutations al-
tered proMMP-2 activation significantly. Thus, reflecting
the expression levels of MT1-MMP mutants on the cell
surface (Figs. 3 B and 4 B), their net cell surface proteolytic
activity did not change significantly compared with that of
the wild-type enzyme.
Figure 5. Internalization of MT1-MMP through clathrin-coated 
vesicles. (A) The interaction of the MT1-MMP cytoplasmic tail with 
the  2 subunit of AP-2 was examined by yeast two-hybrid analysis. 
The cytoplasmic domain sequences derived from MT1-WT and 
MT1-LY/A were expressed as fusion proteins with the GAL4 DNA 
binding domain (bait), while the  2 subunit was expressed as a 
protein fusion with the GAL4 transcription activation domain (prey). 
Protein–protein interaction was detected by the X- -Gal assay. 
Three independent clones of transformed yeasts were analyzed for 
each plasmid combination. TGN38 was a positive control. (B) 
Colocalization of internalizing MT1-F and clathrin. Cells expressing 
MT1-F or its cytoplasmic mutants (L1Y/A and  CP) were incubated 
with Texas red–labeled anti-FLAG M2 antibody (red) on ice, 
washed, and then left at 37 C for 5 min to allow for internalization. 
Clathrin molecules were immunoreacted with goat anti-clathrin 
antibody and visualized with Alexa™488-conjugated anti–goat IgG 
(green). The colocalization of internalizing MT1-F and clathrin was 
observed by washing the cells with acid solution before their fixa-
tion and permeabilization. Signals were then examined by confocal 
laser microscopy. Bar, 5  m.
Figure 6. Effect of cytoplasmic mutations on cell surface events 
mediated by MT1-MMP. (A) CHO-K1 cells were transfected with 
the expression plasmids for various MT1-MMP mutants. The cells 
were incubated with purified proMMP-2 in serum-free culture 
medium. After 18 h, MMP-2 in the culture medium was analyzed 
by gelatin zymography (top). Cell lysates were subjected to Western 
blot analysis using the anti–MT1-MMP monoclonal antibody. (B) 
The cells expressing MT1-F or MT1-F( CP) or mock-transfected 
cells were incubated with 
125I–TIMP-2, and the amount of TIMP-2 
bound to the cells was calculated from the radioactivity. (C) Inter-
nalization of TIMP-2 bound to the cells was analyzed similarly as 
described in Fig. 1. Internalization of TIMP-2 bound to the cells 
expressing MT1-F ( ) or MT1-F( CP) ( ) is plotted. Values in B and 
C are the mean   SD of three experiments. 
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Maquoi et al. (2000) reported recently that MT1-
MMP–bound TIMP-2 is internalized into the cell. Thus,
we examined whether TIMP-2 internalization is indeed
mediated by MT1-MMP. The binding of 
 
125
 
I–TIMP-2 to
the cell surface was observed with cells that expressed either
MT1-F or MT1-F(
 
 
 
CP) (Fig. 6 B). TIMP-2 was internal-
ized if it was bound to MT1-F but not if it was bound to
MT1-F
 
 
 
CP (Fig. 6 C). Thus, the internalization of
TIMP-2 was also dependent on the cytoplasmic sequence
of MT1-MMP.
 
MT1-MMP is internalized at the adherent edge
 
MT1-MMP is mainly localized at the adherent edge and mi-
gration front of cells. This localization appears to be appro-
priate for promoting cell invasion and migration. The con-
tinuous internalization of MT1-MMP at the edge may serve
to substitute inactivated molecules, including TIMP-2 in-
hibited molecules and processed fragments, with freshly syn-
thesized ones during cell migration. To investigate this pos-
sibility further, we examined the internalization of MT1-F
at the cell adherent edge using a confocal laser microscope.
The localization of the enzyme at the adherent layer was
not affected by the mutation that abolishes internalization
(
 
 
 
CP) (Fig. 7 A, Adherent layer and Integrated layers, 0
min). When MT1-F–expressing cells were incubated for 30
min, the wild-type enzyme present at the cell adherent layer
was drastically decreased and internalized molecules were de-
tected (Wild Type, Integrated layers, Adherent layer, and
Intracellular; 30 min). However, when MT1-F(
 
 
 
CP) was
expressed, the signals at the cell adherent layer were not di-
minished even after a 30-min incubation (Adherent layer,
 
 
 
CP). Internalization at this point was also not observed
(Intracellular, 
 
 
 
CP). The number of cells that expressed
MT1-F or MT1-F(
 
 CP) at the adherent edge was also
counted (Fig. 7 B). Thus, the mutation that disturbs the in-
ternalization of MT1-MMP clearly abolishes the active turn-
over of the molecule at the adherent edge. Similar results
were obtained with other internalization-defective mutants
(unpublished data).
Internalization-defective MT1-MMP cannot stimulate 
cell migration
We observed previously that expression of MT1-MMP pro-
motes the migration of CHO-K1 cells (Kajita et al., 2001).
We thus examined whether the internalization-defective mu-
tations also affected the cell migration promoted by MT1-F
(Fig. 8). Migration was analyzed by measuring phagokinetic
tracks of cells on a coverslip coated with BSA and colloidal
gold. Wild-type MT1-F promoted a threefold increase in
CHO-K1 cell migration. This phenomenon requires the cat-
alytic activity of MT1-F because the catalytically inactive E/A
mutant did not promote the motility at all (Fig. 8, A and B).
Interestingly, internalization-defective mutants ( CP and
L1Y/A) did not stimulate motility, whereas the S/A muta-
tion, which has no effect on internalization, did enhance mo-
tility. Other cytoplasmic tail mutants that did not affect in-
ternalization also stimulated motility (unpublished data).
Thus, the internalization of MT1-F correlates with its ability
to promote cell migration. We also confirmed that the inter-
nalization defect of MT1-F does not affect the internalization
of other cell surface molecules, using hTfnR as a representa-
tive molecule (unpublished data).
The above-mentioned experiments were performed on a
BSA-coated coverslip that is different from the gelatin-
coated one used for the experiment in Fig. 7. To confirm
that the coated material does not affect MT1-F internaliza-
tion, we repeated the internalization experiments on a BSA-
coated coverslip. Transfected cells were cultured in the same
conditions that allow cell migration (but without colloidal
gold) and were then analyzed. Although the cell morphology
was different from that on the gelatin coat (Fig. 7), essen-
Figure 7. Localization of MT1-F at the adherent edge and its 
internalization. (A) CHO-K1 cells were cotransfected with the 
plasmids for either MT1-F or  CP mutant and that for GFP. The cells 
were incubated with anti-FLAG M2 antibody, washed, and then 
incubated at 37 C for the indicated periods of time. The M2 
antibody was detected by immunostaining with Cy3-labeled 
anti–mouse IgG. Signals were observed by confocal laser micros-
copy. The internalized antibody was stained using the cells that had 
been acid washed. Adherent layer; confocal section at the adherent 
layer, Integrated layers; integrated confocal layers. Bar, 10  m. (B) 
The number of cells that retained the signals at the adherent layer 
were counted. Transfected cells were identified by GFP expression. 
At time 0, almost 100% of GFP-positive cells expressed MT1-F or 
MT1-F( CP) at the adherent layer. Cells that retained more than 
30% of the original average fluorescence intensity at the adherent 
layer at each time point were counted as positive and presented. 
100 cells were counted independently three times and the values 
presented are the mean   SD.1352 The Journal of Cell Biology | Volume 155, Number 7, 2001
tially the same results were obtained (Fig. 8 C). Thus, cell
migration accompanies active internalization of MT1-MMP
molecules at the migration front, and it appears that a defect
in MT1-MMP internalization also disturbs the migration-
promoting activity of the enzyme.
Correlation between internalization and
invasion-promoting activity of MT1-MMP
It was reported previously that the MT1-MMP mutants
with truncated cytoplasmic tails failed to promote invasion
of the cells into Matrigel, a reconstituted basement mem-
brane (Lehti et al., 2000). Invasion requires a combination
of proteolytic and locomotive cell activities. As internaliza-
tion-defective mutants also lost their ability to promote cell
migration, there might be a possibility that the absence of
invasion was caused by the impaired internalization of
MT1-MMP. We expressed MT1-F and its mutants in
CHO-K1 cells and cellular invasion of Matrigel was exam-
ined. The expression of MT1-F promoted a 6.5-fold in-
crease in cell invasion (Fig. 9), whereas the expression of the
catalytically inactive mutant (E/A) did not. Mutations that
affect MT1-F internalization ( 571,  567,  CP, and L1Y/
A) all severely disturbed the invasion-promoting activity of
the enzyme, whereas those that did not affect internalization
( 579,  575, and S/A) promoted invasion as efficiently as
the wild-type enzyme. The inability of the internalization-
deficient mutants to promote invasion was not due to the
differences in their net proteolytic activity or the amounts of
MT1-F on the cell surface, as demonstrated in Fig. 6, A and
B. Thus, internalization of MT1-MMP seems to be impor-
tant in regulating the enzyme during cell migration and in-
vasion.
Discussion
Internalization of MT1-MMP is regulated by signals in 
its cytoplasmic tail
In this study, we demonstrated that MT1-MMP can be re-
moved from the cell surface by internalization, a process de-
pendent on its cytoplasmic tail sequence. We initially thought
that cell surface events such as processing, inhibition by
TIMP-2, or oligomer formation might trigger or inhibit the
internalization of MT1-MMP at the surface. To examine this,
we studied MT1-MMP internalization using various deletion
mutants that mimic processed products, or under conditions
such as presence or absence of natural and synthetic inhibitors
or monovalent and divalent antibodies (unpublished data).
However, none of these affected the internalization efficiency;
it was solely dependent on the cytoplasmic tail. Based on these
observations, we prefer the idea that the internalization of
MT1-MMP is independent of outside events such as TIMP-2
binding and autodegradation, and therefore this is presum-
ably a system that constitutively cleans up all forms of MT1-
MMP molecules at the surface.
Figure 8. Internalization-defective MT1-MMP mutants cannot 
stimulate cell migration. (A) CHO-K1 cells were transfected with 
the expression plasmids for MT1-F and its mutants. Cell motility was 
analyzed on colloidal gold–coated coverslips. Representative 
phagokinetic tracks of the migrating cell are shown after visualization 
under bright-field illumination. Transfected cells were visualized by 
immunostaining using anti-FLAG antibody. (B) The migration area 
of the cell was visualized under bright-field illumination and analyzed 
using NIH Image software v1.62. The average of 10 cells   SEM is 
shown. The asterisks (*) indicate statistically significant differences (P   0.001) between MT1-F and the mutant. (C) Internalization of MT1-F 
during cell migration was monitored. Transfected cells were seeded on coverslips without colloidal gold and incubated. Cell surface MT1-F 
and its mutant were incubated with Texas red–labeled FLAG M2 antibody. After a 5-min incubation to allow for internalization, surface FLAG 
M2 antibody was removed by acid wash and internalized FLAG M2 antibody was observed by confocal laser microscopy. Actin was stained 
with Alexa
TM488-conjugated phalloidin. Bars, (A) 100  m; (B) 10  m.Internalization of MT1-MMP | Uekita et al. 1353
Unexpectedly, mutations that abrogated the internaliza-
tion did not cause drastic accumulation of MT1-MMP mol-
ecules on the cell surface. They also did not increase the ex-
tent by which MT1-MMP activated proMMP-2 (Fig. 6 A).
This may indicate that there are yet unknown regulations
that adjust the level of MT1-MMP on the cell surface. How-
ever, it is also possible that the transient overexpression used
for the experiments was not appropriate for reflecting the ef-
fect of internalization on the cell surface amount of the en-
zyme. Nevertheless, it is clear that the internalization is de-
pendent on a specific sequence in the cytoplasmic domain,
and mutating this sequence abrogates internalization at the
adherent edge.
Fine mapping of the cytoplasmic domain sequence with
mutants revealed the critical residues to be the LLY
573 motif,
which is a binding site for the  2 subunit of AP-2, a compo-
nent of clathrin-coated vesicles. Confocal laser microscopic
analysis also revealed that the internalized MT1-MMP colo-
calized with clathrin-coated vesicles, indicating strongly that
the MT1-MMP molecules were in the vesicles (Fig. 5 B).
Of the six MT-MMP proteins, four are integral mem-
brane proteinases with a cytoplasmic tail, and two are teth-
ered to the membrane by GPI anchors (Itoh et al., 1999;
Kojima et al., 2000). The reported consensus sequence for
 2 binding is YXXØ (X, any amino acid; Y, tyrosine; Ø,
bulky hydrophobic amino acids; Ohno et al., 1996). The cy-
toplasmic sequence in MT1-MMP (YCQR) is close to the
consensus but does not match completely because Ø is sub-
stituted by the bulky but hydrophilic arginine. The cytoplas-
mic tails of the other three transmembrane MT-MMPs all
contain similar YXXR sequences. The di-leucine motif pre-
ceding the tyrosine in the MT1-MMP cytoplasmic sequence
is also found in MT2- and MT3-MMP, but not in MT5-
MMP. Consistent with this sequence conservation, we
found that MT2- and MT3-MMP are internalized as ef-
fectively as MT1-MMP, whereas MT5-MMP is internal-
ized less efficiently (unpublished data). GPI-anchored type
MT4- and MT6-MMP that lack a cytoplasmic tail are not
internalized efficiently (unpublished data).
Internalization-defective MT1-MMP cannot promote 
cell migration and invasion
Although a defect in MT1-MMP internalization did not af-
fect its net amount on the cell surface nor its ability to acti-
vate proMMP-2, this defect severely disturbed its ability to
promote cell invasion in Matrigel. This observation is con-
sistent with a previous study showing that deletion of the
MT1-MMP cytoplasmic tail reduced its invasion-promoting
activity (Lehti et al., 2000). We found that all the mutations
resulting in poor internalization also abrogated the invasion-
promoting activity of MT1-MMP. Similarly, poor internal-
ization of MT1-MMP also affected its ability to promote
cell motility. Cell surface MT1-MMP has to be regulated
precisely when it functions as a part of invasion machinery.
In addition to its proteolytic activity, the enzyme has to be at
the right site at the right time on the cell surface together
with the right partners, and then it is inhibited by TIMP-2
or partially degraded. These “old molecules” have to be
cleared off to assure substitution with the newly synthesized
molecules. Thus, it is very plausible that the proteolytic ac-
tivity of MT1-MMP is critical but not sufficient for a bio-
logical outcome such as invasion.
During cell migration, MT1-MMP localizes predomi-
nantly to the cell adherent edge and the migration front. Be-
cause such localization is presumably important in regulat-
ing cell locomotion, we speculated first that the mutations in
the cytoplasmic sequence affect such localization and even-
tually abrogate cell migration and invasion. However, this
was not the case, as shown in Fig. 7. Consistent with the lo-
calization site of MT1-MMP, internalization of the enzyme
was mostly observed there. Accordingly, whereas surface-
labeled wild-type MT1-F disappeared over time at the ad-
herent edge, the levels of the  CP mutant decreased very slowly
(Fig. 8, A and B). Thus, the mutations that prevent internal-
ization of MT1-MMP molecules disturb the turnover of the
enzyme at the migration front. The adherent edge and mi-
gration front are where the proteases and cell adhesion mole-
cules that regulate cell locomotion and invasion congregate.
However, our knowledge of the molecules involved and the
way they operate in these processes is at present not suffi-
cient to completely understand the role of MT1-MMP in-
ternalization. One possible idea is that internalization may
be a mechanism to prevent accumulation of inactivated
MT1-MMP, such as TIMP-2–inhibited or partially de-
graded molecules, which may disturb their substitution with
freshly synthesized enzymes. If this is the case, internaliza-
tion-defective mutants are expected to disturb the function
of the wild-type enzyme. Indeed, expression of such mutant
MT-MMP molecules in the cells expressing the wild-type
enzyme inhibited the migration and invasion-stimulating ac-
tivity of the wild-type MT1-MMP (unpublished data). This
dominant-negative effect of the mutant against the wild-
type enzyme indicates again that proteolytic activity of
Figure 9. Effect of the mutations on Matrigel invasion. CHO-K1 
cells were transfected with the expression plasmids for MT1-F, its 
mutants, or empty vector together with a GFP plasmid. Cells were 
then subjected to the Matrigel invasion assay. After 48 h of incubation, 
the invaded GFP-positive cells on the lower surface of the filters 
were counted under fluorescence microscopy. Each assay was 
performed in triplicate and numbers shown are the mean   SD. The 
asterisks (*) indicate statistically significant differences (P   0.001) 
between the cells expressing wild-type and mutant MT1-MMP 
molecules.1354 The Journal of Cell Biology | Volume 155, Number 7, 2001
MT1-MMP is important but not sufficient to promote cell
migration and invasion.
A recent study has described somewhat contrary results
about the role of the MT1-MMP cytoplasmic tail on inva-
sion-promoting activity. Namely, expression of the MT1-
MMP mutant lacking a cytoplasmic tail still promoted inva-
sion of COS-1 cells in a type I collagen gel, same as the
wild-type enzyme did (Hotary et al., 2000). Because we used
CHO-K1 cells and Matrigel for the assay, we tried to repro-
duce their experiments first. Expression of the MT1-F deriv-
atives in COS-1 cells and analysis of the invasion in a type I
collagen gel revealed that internalization-defective mutants
also promoted invasion, confirming Hotary’s results (un-
published data). However, when the same cells were ana-
lyzed in Matrigel, the results were similar to those obtained
in this study using CHO-K1 cells. Thus, the requirement of
the cytoplasmic tail for the invasion-promoting activity of
MT1-MMP seems to differ depending on the matrix used
for the assay. It should be noted that Matrigel contains com-
plex ECM components, some of them cannot be degraded
by MT1-MMP, whereas type I collagen gel contains a single
component that is a good substrate for MT1-MMP (Ohuchi
et al., 1997). Consequently, the collagen gel may be loos-
ened more easily than Matrigel by MT1-MMP, and the cells
may be able to move through the residual type I collagen
matrix easily even when their locomotive force was reduced
by the expression of internalization-defective mutants. Thus,
the migration-promoting activity of MT1-MMP may play a
more important role when the cells are moving through the
residual Matrigel matrix rather than the loosened type I col-
lagen gel.
Nakahara et al. (1997) have previously suggested that the
cytoplasmic tail of MT1-MMP may play a role in localizing
the enzyme to the protruding membrane structure known as
the invadopodium, which is frequently associated with inva-
sive cancer cells. In our experiments, CHO-K1 cells do not
form obvious invadopodial structures and the localization of
MT1-MMP at the cell adherent edge is not affected by mu-
tations in the cytoplasmic tail. Similar observations were also
made with COS-1 and HT1080 cells (unpublished data).
Although the molecular characterization of invadopodia is
not sufficient to understand how its formation is regulated
(Chen and Wang, 1999), the cytoplasmic tail of MT1-
MMP may interact with a certain molecule that exists in the
invadopodia. It is also possible that the formation of the in-
vadopodia itself might be disturbed by the internalization-
defective MT1-MMP mutants because formation of these
structures requires local invasion.
In conclusion, our study indicates that the cytoplasmic tail
of MT1-MMP is critical for the internalization of MT1-
MMP molecules at the cell surface, presumably after their in-
corporation into clathrin-coated vesicles. During cell migra-
tion, MT1-MMP localizes predominantly to the migration
front and is internalized there. Mutations that disturb the in-
ternalization caused accumulation of the molecules at the ad-
herent edge and abrogated cell migration and invasion. Thus,
dynamic turnover of MT1-MMP molecules at the migration
front by internalization appears critical to the migration-
stimulating activity of MT1-MMP. This is a newly discov-
ered mechanism that regulates the action of pericellular pro-
teases during cell migration and sheds light on the dynamic
events at the migration front that control cell locomotion, a
field that is still unclear. Further study is needed to precisely
delineate the sequential events that regulate proteases and cell
adhesion molecules in relation to actin dynamics.
Materials and methods
Cell culture and transfection
CHO-K1 cells were cultured at 37 C in Ham’s F-12 medium (Sigma-
Aldrich) supplemented with 10% FBS, 1% kanamycin, and MEM nones-
sential amino acid solution (Invitrogen). For transfection, cells were seeded
in six-well plates at 1.5   10
5 cells/well and transfection was performed
after 16 h. Expression vectors were transfected using FuGENE6™ (Roche
Molecular Biochemicals) according to the manufacturer’s instructions.
Construction of FLAG-tagged human MT1-MMP mutants 
and hTfnR
FLAG epitope (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys)–tagged MT1-MMP (de-
noted as MT1-F) was constructed as previously described (Itoh et al., 1999)
and subcloned into the pSG5 expression vector (Stratagene). This plasmid
was used as a template for PCR-based modification to generate mutant
MT1-MMPs.
MT1-F(EA) is the catalytically inactive mutant (Glu
240 to Ala). MT1-
F( PEX) is the hemopexin-like domain–deleted mutant ( Ile
318–Gly
535),
and MT1-F( CAT) is the catalytic domain–deleted mutant ( Tyr
112–Pro
312).
MT1-F(IL2R) is the chimera of the ectodomain of MT1-F and the trans-
membrane/cytoplasmic domain of IL2R. MT1-F(GPI) is the chimeric mu-
tant of MT1-F (Met
1–Cys
508) and the GPI-anchoring signal derived from
MT4-MMP (Gly
526–Leu
607). Cytoplasmic deletion mutants of MT1-MMP
( 579,  575,  571,  567, and  CP) were generated by introducing a stop
codon in the plasmid, and site-directed mutations ( 571–574, L1/A, Y/A,
S/A, L2/A, V/A, L1Y/A, L1L2/A, and L1YL2/A) were generated by PCR-
based mutation methods. All the PCR products were confirmed by DNA
sequencing and the cDNAs subsequently generated were subcloned into a
pSG5 mammalian expression vector (Stratagene).
Full-length hTfnR cDNA was amplified by reverse transcript PCR us-
ing total RNA obtained from HT1080 cells and subcloned into the
pcDNA3.1( ) expression vector (Invitrogen).
Western blot analysis
Transfected cells were washed three times with PBS and lysed in SDS-
PAGE loading buffer containing 2-mercaptoethanol. Proteins were sepa-
rated by SDS-PAGE and transferred to a nitrocellulose membrane (Hy-
bond-ECL; Amersham Pharmacia Biotech). After blocking the membrane
with 10% fat-free dry milk in Tris-buffered saline (TBS; 20 mM Tris-HCl,
pH 7.5, 150 mM NaCl), the membrane was probed with anti-FLAG M2
monoclonal antibody (Sigma-Aldrich) (5  g/ml) to detect FLAG-tagged
MT1-MMP (MT1-F) and its mutants. An hTfnR-specific antibody was used
to detect control cells transfected with hTfnR. The membrane was further
probed with alkaline phosphatase–conjugated anti–mouse IgG (Sigma-
Aldrich) to visualize the antibody.
Iodination of human holo-transferrin, anti-FLAG M2 antibody, 
and rTIMP-2
The proteins were labeled with 
125I using IODO-GEN (Pierce Chemical Co.)
in TBS containing 0.05% Brij35. After the reaction, free 
125I was removed by
gel filtration on Sephadex™ G-25 (Amersham Pharmacia Biotech).
Internalization assay
Transfected CHO-K1 cells were seeded onto gelatin-coated 12-well plates
(10
6 cells/well). After 24 h, cells were incubated for 1 h on ice with 2  g/
ml 
125I-labeled anti-FLAG M2 IgG, holo transferrin, or TIMP-2 in internal-
ization medium (Ham’s F-12 medium containing 0.1% FBS, 1% kanamy-
cin, and MEM supplemented with nonessential amino acids). 10  M of
peptidyl hydroxamate MMP inhibitor, BB94 (provided by Dr. Peter D.
Brown, British Biotech Pharmaceuticals Ltd., Oxford, UK), was included
during the incubation with the M2 antibody to avoid the autodegradation
of MT1-MMP. Cells were washed with chilled medium three times and in-
cubated further at 37 C for the indicated period of time in each experi-
ment. At the end of the incubation, culture supernatants were collected to
measure the 
125I-labeled proteins that had been released by the cells. 
125I-
labeled proteins on the cell surface were collected by washing the cellsInternalization of MT1-MMP | Uekita et al. 1355
with acid solution (500 mM CH3COOH, 150 mM NaCl) for 5 min at 4 C.
This allows more than 98% of cell surface–bound ligand to be recovered.
After the acid wash, cells were dissolved in lysis buffer (100 mM NaOH,
150 mM NaCl) to measure the proteins that had been internalized. Radio-
activity in each fraction was measured by a gamma counter.
Indirect immunofluorescence staining
Transfected CHO-K1 cells were seeded on gelatin-coated coverslips. After
24 h, the cells were incubated for 1 h at 4 C with mouse anti-FLAG M2 (5
 g/ml) in internalization medium supplemented with 10  M BB94. The
cells were then washed with chilled medium three times, incubated at
37 C, and fixed with 3% paraformaldehyde in PBS. After blocking with 5%
goat serum and 3% BSA in PBS for 1 h at room temperature, mouse anti-
FLAG M2 antibody–treated cells were incubated with Alexa™488-conju-
gated goat anti–mouse IgG (Molecular Probes, Inc.) or Cy3-conjugated
goat anti–mouse IgG (Jackson ImmunoResearch Laboratories). For clathrin
staining, fixed cells were incubated with goat anti-clathrin HC (C-20) anti-
body and visualized with Alexa™488-conjugated rabbit anti–goat IgG
(Molecular Probes, Inc.). Actin was stained with Alexa™488-conjugated
phalloidin. Fluorescence signals were detected using a Bio-Rad MRC-1024
confocal laser microscope.
Yeast two-hybrid analysis
Yeast two-hybrid assays were performed as described in the instructions
for the MATCHMAKER two-hybrid kit using yeast strain Y190 (CLONTECH
Laboratories, Inc.) with a modification described previously (Ohno et al.,
1996). In brief, plasmids encoding the GAL4 binding domain fused with
the MT1-MMP cytoplasmic domain (R
563–V
582) or the cytoplasmic domain
mutant (LLY
573/AAA) were constructed using a PCR-based technique and
subcloned into the pGBT9 vector. These constructs were tested for interac-
tion with GAL4 fused to activation domain  2 using X- -Gal (CLONTECH
Laboratories, Inc.).
Gelatin zymography
Gelatin zymography was performed as described previously (Sato et al.,
1994). Samples were mixed with SDS sample buffer without a reducing
agent and separated in 7.5% acrylamide gels containing 0.1% gelatin. The
gels were incubated at 37 C after removing SDS by washing with 2.5% Tri-
ton X-100–containing buffer. The gels were stained with Coomassie bril-
liant blue R250, and the gelatinolytic activities were detected as clear
bands against a blue background.
Matrigel invasion assay
The Matrigel invasion assay was performed as described previously (Itoh et
al., 2001) according to manufacturer’s instructions (Becton Dickinson).
MT1-MMP (wild-type or mutant) expression plasmids were cotransfected
into CHO-K1 cells with the green fluorescent protein (GFP) expression
plasmid. The transfected cells were suspended in Ham’s F-12 medium
without serum and seeded onto Matrigel-coated transwell filters (8- m
pore) in invasion chambers. FBS (10%)-containing medium was added to
the lower chambers and incubated for 48 h. Noninvading cells remaining
on the upper surface of the filter were removed and fixed with 3% parafor-
maldehyde. The GFP-positive cells appearing on the lower surface of the
filter were counted by fluorescence microscopy. Each assay was per-
formed in triplicate.
Phagokinetic track motility assay
The phagokinetic track motility assay was performed as described previously
(Kajita et al., 2001). Colloidal gold–coated coverslips were placed in a 12-
well plate and transfected cells were seeded at 3   10
3 cells/well. After 12 h
of incubation, the phagokinetic tracks were visualized under bright-field illu-
mination using a CoolSNAP-fx monochrome CCD camera (Roper Scientific).
The track area was measured using NIH Image software v1.62.
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